Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


A new mechanism triggering cell death and inflammation: a left turn that kills


Writing in ‘Nature’, researchers from Cologne, Texas and London describe their discovery of a new mechanism that could contribute to the pathogenesis of inflammatory diseases.

The scientists found that ZBP1, a protein best known for defending against incoming viruses, is activated by sensing an unusual form of cellular genetic material (Z-nucleic acids), leading to cell death and inflammation.

Z-form nucleic acids are double-stranded DNA and RNA molecules with an unusual left-handed double helix structure, as opposed to the classical right-handed Watson-Crick double helix. Z-nucleic acids were discovered more than 40 years ago, but their biological function has remained poorly understood.

The group of Professor Manolis Pasparakis at the CECAD Cluster of Excellence in Aging Research of the University of Cologne cooperated with scientists from the University of Texas Health Science Center and the Francis Crick Institute in London to study the role of Z-DNA Binding Protein 1 (ZBP1), one of only two proteins in mammals that senses Z-nucleic acids.

ZBP1 was previously shown to sense the genetic material of certain viruses and induce the death of the infected cells to prevent viral spread.

Curiously, in their earlier studies, the researchers obtained evidence that ZBP1 can also cause cell death and inflammation in the absence of viral infection.

They had found that when the function of RIPK1 – a protein inhibiting ZBP1 – was compromised, ZBP1 was activated and triggered an inflammatory type of cell death, called necroptosis. A key question behind the current study was how ZBP1 can be activated in the absence of incoming viral infection.

Using experimental mouse models, the scientists found that the proinflammatory activity of ZBP1 depended on its ability to bind Z-nucleic acids, suggesting that it is activated by Z-form nucleic acids that existed within the cell. The next question was what type of endogenous nucleic acids are bound by ZBP1.

‘We could show that ZBP1 binds to double-stranded RNA’, Pasparakis said. ‘Although we currently lack the experimental methodology to demonstrate that this has the Z-conformation, based on all available structural studies, our interpretation of our results is that ZBP1 binds to endogenous Z-RNA via its Z domains.’

Double-stranded RNA (dsRNA) is uncommon in cells but forms during the replication of certain viral genomes, and is thought to provide the ligand activating ZBP1 during viral infection. The scientists hypothesized that cellular dsRNA could be produced by endogenous retroelements, which are forms of parasitic DNA derived either from ancient retroviral infections or from active retrotransposons or ‘jumping genes’, which constitute over half of the human and mouse genomes.

To address the possible role of endogenous retroelements as sources of dsRNA, the team of Manolis Pasparakis collaborated with George Kassiotis’ Retroviral Immunology Laboratory at the Francis Crick Institute.

Indeed, computational analysis of RNA sequencing data from mouse skin showed that most complementary, putatively double-stranded, RNA was derived from particular groups of endogenous retroelements.

These findings suggested that sensing of cellular dsRNA, most likely derived from endogenous retroelements, activates ZBP1, inducing cell death and inflammation. This mechanism may be relevant for the pathogenesis of inflammatory pathologies in humans, particularly in patients with mutations of proteins inhibiting ZBP1 such as RIPK1.

‘Z-form nucleic acids have remained mysterious for so many years’, Pasparakis remarked. ‘Currently, our only means to investigate their function is by studying the proteins that sense them. We made some progress, but the challenge ahead would be to understand why, where and how they form within a cell and what the purpose of this is.’

A particularly fascinating aspect is the link to endogenous retroelements. ‘We currently understand very little about how these genomic parasites affect our health. It appears that over the course of evolution, some retrotransposons, which can mimic viral infection, have been recruited as useful partners in the response of our cells to damage, stress or true infection, but this partnership can also go wrong, causing disease’, Kassiotis commented.

‘Just like during viral infection, sensing of Z-RNA produced by endogenous retroelements by ZBP1 could provide a potent trigger for cell death and inflammation, and cause disease. These are early days and we have a long way to go, but understanding the underlying mechanisms may one day lead to novel therapies for human diseases’, Pasparakis concluded.

Media Contact:
Professor Dr. Manolis Pasparakis
Press and Communications Team:
Robert Hahn
+49 0221 470 2396

‘Z-nucleic-acid sensing triggers ZBP1 dependent necroptosis and inflammation’, Nature, DOI:10.1038/s41586-020-2129-8

Gabriele Meseg-Rutzen | idw - Informationsdienst Wissenschaft
Further information:

More articles from Life Sciences:

nachricht Biophysicists reveal how optogenetic tool works
29.05.2020 | Moscow Institute of Physics and Technology

nachricht Mapping immune cells in brain tumors
29.05.2020 | University of Zurich

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Biotechnology: Triggered by light, a novel way to switch on an enzyme

In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".

Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...

Im Focus: New double-contrast technique picks up small tumors on MRI

Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.

researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...

Im Focus: I-call - When microimplants communicate with each other / Innovation driver digitization - "Smart Health“

Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.

When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...

Im Focus: When predictions of theoretical chemists become reality

Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.

Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...

Im Focus: Rolling into the deep

Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.

A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

Dresden Nexus Conference 2020: Same Time, Virtual Format, Registration Opened

19.05.2020 | Event News

Aachen Machine Tool Colloquium AWK'21 will take place on June 10 and 11, 2021

07.04.2020 | Event News

International Coral Reef Symposium in Bremen Postponed by a Year

06.04.2020 | Event News

Latest News

Black nitrogen: Bayreuth researchers discover new high-pressure material and solve a puzzle of the periodic table

29.05.2020 | Materials Sciences

Argonne researchers create active material out of microscopic spinning particles

29.05.2020 | Materials Sciences

Smart windows that self-illuminate on rainy days

29.05.2020 | Power and Electrical Engineering

Science & Research
Overview of more VideoLinks >>>